William Blair Starts Neurogene (NGNE) at Outperform, 'The Goldilocks of Gene Therapy'

March 21, 2024 5:18 AM EDT Send to a Friend
(Updated - March 21, 2024 7:34 AM EDT)

William Blair analyst Sami Corwin initiates coverage on Neurogene (NASDAQ: NGNE) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login